Pak Fah Yeow International Limited (0239) AI Stock Analysis

• Market Cap: HK$754.17M
• Dividend Yield: 8.88%
• Average Volume (3M): 26.60K
• Price to Earnings (P/E): 9.6
• Beta (1Y): <0.01
• Revenue Growth: -8.64%
• EPS Growth: -25.13%
• Country: HK
• Employees: 106
• Sector: Healthcare
• Sector Strength: 42
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): 0.25
• Shares Outstanding: 311,640,000
• 10 Day Avg. Volume: 34,300
• 30 Day Avg. Volume: 26,600
• PEG Ratio: -0.47
• Price to Book (P/B): 0.98
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 8.21
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 71 Outperform
• Price Target: ―

Pak Fah Yeow International Limited shows a stable financial structure with strong asset backing and minimal leverage. However, challenges in revenue growth and declining net margins present operational risks. The stock's valuation is a strong point, given its low P/E ratio and high dividend yield, making it an attractive option for value and income-focused investors despite mixed technical indicators.

Pak Fah Yeow International Limited Business Overview & Revenue Model

Company Description

Pak Fah Yeow International Limited (0239) is a Hong Kong-based company primarily engaged in the manufacturing and distribution of healthcare products. The company is best known for its flagship product, White Flower Embrocation, a medicated oil used for relief of pain and various ailments. Pak Fah Yeow operates in the healthcare sector, focusing on traditional medicated oils and related products.

How the Company Makes Money

Pak Fah Yeow International Limited generates revenue through the production and sale of its healthcare products, primarily the White Flower Embrocation. The company sells its products domestically in Hong Kong and internationally across various markets, including Southeast Asia, North America, and Europe. Revenue streams are derived from direct sales to consumers through retail channels, as well as distribution agreements with wholesalers and retailers. The company may also engage in marketing partnerships or sponsorships to increase brand visibility and product reach. With a strong brand legacy and recognition, Pak Fah Yeow leverages its traditional formulation to maintain a loyal customer base and sustain its revenue.

Pak Fah Yeow International Limited Financial Statement Overview

Summary

Pak Fah Yeow International Limited displays a robust balance sheet with minimal leverage and strong asset backing. However, declining revenue and net profit margins, alongside a decrease in return on equity, present challenges. The absence of complete cash flow data for 2024 limits the assessment of liquidity.

Income Statement

The company demonstrated a mixed financial performance. While the EBIT margin was strong at 41.42% and EBITDA margin at 56.19% in 2024, the net profit margin declined to 33.11% from 40.50% in 2023. Revenue in 2024 showed a negative growth rate of -8.43% compared to 2023, indicating challenges in maintaining revenue growth.

Balance Sheet

The balance sheet is robust, with a low debt-to-equity ratio of 0.01, indicating minimal leverage. The equity ratio stands at a healthy 86.77%, reflecting strong asset backing. However, the return on equity decreased to 10.75% in 2024 from 13.73% in 2023, showing a decline in profitability on equity.

Cash Flow

Cash flow analysis is limited due to missing data for 2024. In 2023, the operating cash flow to net income ratio was 1.41, indicating efficient conversion of profits into cash flow. Free cash flow growth was not calculable for 2024 due to unavailable data, presenting a challenge in assessing cash flow trends.

Breakdown
Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
236.91M	259.31M	147.20M	139.82M	109.34M
	Gross Profit
203.20M	167.59M	74.06M	68.71M	41.48M
	EBIT
98.35M	143.01M	46.22M	45.02M	26.55M
	EBITDA
105.73M	136.81M	53.71M	52.20M	-25.22M
	Net Income Common Stockholders
78.63M	105.04M	29.95M	38.19M	-38.36M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
290.02M	277.61M	180.34M	178.28M	131.48M
	Total Assets
843.35M	907.47M	823.14M	837.75M	795.40M
	Total Debt
4.20M	4.74M	7.57M	18.29M	19.93M
	Net Debt
-271.61M	-260.78M	-161.87M	-146.38M	-97.37M
	Total Liabilities
111.45M	142.28M	115.91M	130.03M	122.20M
	Stockholders Equity
731.91M	765.18M	707.23M	707.72M	673.19M
Cash Flow		Free Cash Flow
0.00	144.84M	39.76M	69.54M	7.62M
	Operating Cash Flow
0.00	147.90M	39.92M	70.36M	8.26M
	Investing Cash Flow
0.00	16.65M	-156.00K	-565.00K	-637.00K
	Financing Cash Flow
0.00	-48.96M	-33.91M	-22.41M	-29.07M

Pak Fah Yeow International Limited Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 2.42
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0239, the sentiment is Positive. The current price of 2.42 is above the 20-day moving average (MA) of 2.33, above the 50-day MA of 2.26, and above the 200-day MA of 2.38, indicating a bullish trend. The MACD of 0.04 indicates Negative momentum. The RSI at 68.02 is Neutral, neither overbought nor oversold. The STOCH value of 94.87 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:0239.

Pak Fah Yeow International Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
0146	75 Outperform	HK$265.23M	6.39	9.39%	9.45%	0.05%	-26.73%
0239	71 Outperform	HK$754.17M	9.59	10.50%	8.88%	-8.64%	-25.13%
Sector *	53 Neutral	$5.14B	3.03	-43.89%	2.83%	16.75%	-0.06%
0271	45 Neutral	HK$203.47M	0.82	-4.19%	―	-3.42%	-128.18%

Pak Fah Yeow International Limited Corporate Events

Pak Fah Yeow International Limited Announces AGM and Share Repurchase Plan

Pak Fah Yeow International Limited has announced its upcoming annual general meeting scheduled for June 16, 2025, in Hong Kong. Key agenda items include the consideration of financial statements for the year ending December 2024, the declaration of a final and special dividend, re-election of directors, and the re-appointment of auditors. Additionally, the company seeks approval for a share repurchase program, allowing the repurchase of up to 10% of its issued shares, which could impact its market positioning and shareholder value.

Pak Fah Yeow Reports Decline in 2024 Profits Amid Healthcare Sales Slump

Pak Fah Yeow International Limited reported a decrease in revenue and underlying recurring profit by 8.6% and 13.0% respectively, primarily due to a decline in sales in its healthcare business. The reported profit fell by 25.1%, largely due to higher non-cash fair value losses on investment properties. Despite these declines, the company proposed a final dividend of HK3.8 cents per share and a special final dividend of HK6.7 cents per share, indicating a commitment to returning value to shareholders.

Pak Fah Yeow Announces Final and Special Dividends for 2024

Pak Fah Yeow International Limited announced a recommendation for a final dividend of HK3.8 cents per share and a special final dividend of HK6.7 cents per share for the year ended 31 December 2024. These dividends are subject to approval at the annual general meeting on 16 June 2025, with payment scheduled for 8 August 2025. The announcement indicates a positive financial performance, potentially enhancing shareholder value and reflecting the company’s stable position in the healthcare market.

Pak Fah Yeow Declares Final Dividend for 2024

Pak Fah Yeow International Limited announced a final ordinary cash dividend of HKD 0.038 per share for the financial year ending December 31, 2024. The dividend will be paid on August 8, 2025, following shareholder approval on June 16, 2025, and is expected to reinforce shareholder value and reflect the company’s stable financial performance.

Pak Fah Yeow International Announces Special Final Dividend for 2024

Pak Fah Yeow International Limited has announced a special final dividend of HKD 0.067 per share for the financial year ending December 31, 2024. The dividend will be paid on August 8, 2025, following shareholder approval on June 16, 2025. This announcement reflects the company’s commitment to returning value to its shareholders and may positively impact investor sentiment.

Pak Fah Yeow International to Announce Annual Results and Dividend Decision

Pak Fah Yeow International Limited has announced that its Board of Directors will meet on March 27, 2025, to approve the company’s annual results and decide on the final dividend for the year ending December 31, 2024. This meeting is significant as it will determine the company’s financial performance and potential returns for stakeholders, impacting its market positioning and investor confidence.

Pak Fah Yeow International Issues Profit Warning for 2024

Pak Fah Yeow International Limited has issued a profit warning, anticipating a decrease in consolidated net profit to approximately HK$78.0 million for the year ending December 31, 2024, down from HK$105.0 million in 2023. This decline is attributed to a reduction in total revenue and an unrealized fair value loss on investment properties, though partially offset by reduced tax expenses. Despite these challenges, the company’s overall financial position remains healthy, with no impact on operating cash flow.